{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T18:02:07Z","timestamp":1751306527548},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1208\/s12249-014-0250-4","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T20:35:58Z","timestamp":1418243758000},"page":"645-655","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pediatric Suppositories of Sulpiride Solid Dispersion for Treatment of Tourette Syndrome: In Vitro and In Vivo Investigations"],"prefix":"10.1208","volume":"16","author":[{"given":"Ahmed S.","family":"Zidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif E.","family":"Emam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer M.","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakhr-eldin S.","family":"Ghazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"issue":"Pt 3","key":"250_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/brain\/123.3.425","volume":"123","author":"MM Robertson","year":"2000","unstructured":"Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 2000;123(Pt 3):425\u201362.","journal-title":"Brain"},{"key":"250_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0145445514522056","volume":"38","author":"J Buse","year":"2014","unstructured":"Buse J, Kirschbaum C, Leckman JF, Munchau A, Roessner V. The modulating role of stress in the onset and course of Tourette\u2019s syndrome: a review. Behav Modif. 2014;38:184\u2013216.","journal-title":"Behav Modif"},{"key":"250_CR3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00115-006-2131-x","volume":"78","author":"KR Muller-Vahl","year":"2007","unstructured":"Muller-Vahl KR. The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette\u2019s syndrome. Der Nervenarzt. 2007;78:264. p. 266\u2013268, 270\u2013271.","journal-title":"Der Nervenarzt"},{"key":"250_CR4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10654-005-2953-z","volume":"20","author":"R Jin","year":"2005","unstructured":"Jin R, Zheng RY, Huang WW, Xu HQ, Shao B, Chen H, et al. Epidemiological survey of Tourette syndrome in children and adolescents in Wenzhou of P.R. China. Eur J Epidemiol. 2005;20:925\u20137.","journal-title":"Eur J Epidemiol"},{"key":"250_CR5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1211\/jpp.59.8.0001","volume":"59","author":"TB Ernest","year":"2007","unstructured":"Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL. Developing paediatric medicines: identifying the needs and recognizing the challenges. J Pharm Pharmacol. 2007;59:1043\u201355.","journal-title":"J Pharm Pharmacol"},{"key":"250_CR6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-3156.2009.02299.x","volume":"14","author":"DO Simba","year":"2009","unstructured":"Simba DO, Warsame M, Kimbute O, Kakoko D, Petzold M, Tomson G, et al. Factors influencing adherence to referral advice following pre-referral treatment with artesunate suppositories in children in rural Tanzania. Trop Med Int Health. 2009;14:775\u201383.","journal-title":"Trop Med Int Health"},{"key":"250_CR7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jphp.12136","volume":"65","author":"RA Mohamed","year":"2013","unstructured":"Mohamed RA, Abass HA, Attia MA, Heikal OA. Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository. J Pharm Pharmacol. 2013;65:1607\u201321.","journal-title":"J Pharm Pharmacol"},{"key":"250_CR8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijpharm.2012.07.030","volume":"436","author":"T Kauss","year":"2012","unstructured":"Kauss T, Gaudin K, Gaubert A, Ba B, Tagliaferri S, Fawaz F, et al. Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment. Int J Pharm. 2012;436:624\u201330.","journal-title":"Int J Pharm"},{"key":"250_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00558453","volume":"17","author":"FA Wiesel","year":"1980","unstructured":"Wiesel FA, Alfredsson G, Ehrnebo M, Sedvall G. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. Eur J Clin Pharmacol. 1980;17:385\u201391.","journal-title":"Eur J Clin Pharmacol"},{"key":"250_CR10","first-page":"902","volume":"32","author":"SE Emam","year":"2013","unstructured":"Emam SE, Ghazy FS, Zidan AS, Shehata TM. Solid dispersion approach for optimized bioavailability of sulpiride. Lat Am J Pharm. 2013;32:902\u201310.","journal-title":"Lat Am J Pharm"},{"key":"250_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpharm.2014.02.004","volume":"465","author":"Y Lu","year":"2014","unstructured":"Lu Y, Tang N, Lian R, Qi J, Wu W. Understanding the relationship between wettability and dissolution of solid dispersion. Int J Pharm. 2014;465:25\u201331.","journal-title":"Int J Pharm"},{"key":"250_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10717540600640278","volume":"14","author":"RJ Chokshi","year":"2007","unstructured":"Chokshi RJ, Zia H, Sandhu HK, Shah NH, Malick WA. Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons. Drug Deliv. 2007;14:33\u201345.","journal-title":"Drug Deliv"},{"key":"250_CR13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/03639040500214613","volume":"31","author":"MM Varma","year":"2005","unstructured":"Varma MM, Pandi JK. Dissolution, solubility, XRD, and DSC studies on flurbiprofen-nicotinamide solid dispersions. Drug Dev Ind Pharm. 2005;31:417\u201323.","journal-title":"Drug Dev Ind Pharm"},{"key":"250_CR14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.carbpol.2014.01.027","volume":"104","author":"LD Alves","year":"2014","unstructured":"Alves LD, de La Roca Soares MF, de Albuquerque CT, da Silva ER, Vieira AC, Fontes DA, et al. Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods. Carbohydr Polym. 2014;104:166\u201374.","journal-title":"Carbohydr Polym"},{"key":"250_CR15","unstructured":"USP35\/NF30, 2012. United States Pharmacopoeia\/National Formulary (USP35\/NF30), The United States Pharmacopoeial Convention, Rockville, MD, 2012."},{"key":"250_CR16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2012.11.040","volume":"441","author":"T Kauss","year":"2013","unstructured":"Kauss T, Gaubert A, Boyer C, Ba BB, Manse M, Massip S, et al. Pharmaceutical development and optimization of azithromycin suppository for paediatric use. Int J Pharm. 2013;441:218\u201326.","journal-title":"Int J Pharm"},{"key":"250_CR17","unstructured":"Allen LV. Suppositories first edition. In: J.L.V. A, editor. First ed. London-Chicago: Pharmaceutical Press; 2007. p. 139\u201347."},{"key":"250_CR18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.farmac.2004.07.006","volume":"59","author":"J Hanaee","year":"2004","unstructured":"Hanaee J, Javadzadeh Y, Taftachi S, Farid D, Nokhodchi A. The role of various surfactants on the release of salbutamol from suppositories. Farmaco. 2004;59:903\u20136.","journal-title":"Farmaco"},{"key":"250_CR19","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/j.jchromb.2011.10.032","volume":"879","author":"M Nobilis","year":"2011","unstructured":"Nobilis M, Vybiralova Z, Szotakova B, Sladkova K, Kunes M, Svoboda Z. High-performance liquid chromatographic determination of tiapride and its phase I metabolite in blood plasma using tandem UV photodiode-array and fluorescence detection. J Chromatogr B Anal Technol Biomed Life Sci. 2011;879:3845\u201352.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"250_CR20","unstructured":"WHO. Proposal to waive in vivo bioequivalence requirements for the WHO model list of essential medicines immediate release, solid oral dosage forms. In: WHO, editor. Geneva: World Health Organization; 2005. p. 1\u201344."},{"key":"250_CR21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2174\/187221111797200551","volume":"5","author":"B Iqbal","year":"2011","unstructured":"Iqbal B, Ali A, Ali J, Baboota S, Gupta S, Dang S, et al. Recent advances and patents in solid dispersion technology. Recent Patents Drug Deliv Formulation. 2011;5:244\u201364.","journal-title":"Recent Patents Drug Deliv Formulation"},{"key":"250_CR22","first-page":"9","volume":"3","author":"A Kalia","year":"2011","unstructured":"Kalia A, Poddar M. Solid dispersions: an approach towards enhancing dissolution rate. Int J Pharm Pharm Sci. 2011;3:9\u201319.","journal-title":"Int J Pharm Pharm Sci"},{"key":"250_CR23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jps.2600810106","volume":"81","author":"F Bressolle","year":"1992","unstructured":"Bressolle F, Bres J, Faure-Jeantis A. Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans. J Pharm Sci. 1992;81:26\u201332.","journal-title":"J Pharm Sci"},{"key":"250_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpba.2014.03.019","volume":"96","author":"K Yuvaraja","year":"2014","unstructured":"Yuvaraja K, Khanam J. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid. J Pharm Biomed Anal. 2014;96:10\u201320.","journal-title":"J Pharm Biomed Anal"},{"key":"250_CR25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0278-6915(82)80289-5","volume":"20","author":"AJ Ingram","year":"1982","unstructured":"Ingram AJ, Butterworth KR, Gaunt IF, Gangolli SD. Short-term toxicity study of metatartaric acid in rats. Food Chem Toxicol. 1982;20:253\u20137.","journal-title":"Food Chem Toxicol"},{"key":"250_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5173(95)00069-U","volume":"124","author":"T Oribe","year":"1995","unstructured":"Oribe T, Yamada M, Takeuchi K, Tsunemi S, Imasaka K, Shirakura O, et al. Formulation and in vivo-in vitro correlation of the dissolution property of lemildipine solid dispersions-incorporated suppositories. Int J Pharm. 1995;124:27\u201335.","journal-title":"Int J Pharm"},{"key":"250_CR27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jps.20754","volume":"96","author":"SR Vippagunta","year":"2007","unstructured":"Vippagunta SR, Wang Z, Hornung S, Krill SL. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci. 2007;96:294\u2013304.","journal-title":"J Pharm Sci"},{"key":"250_CR28","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1166\/jnn.2013.7643","volume":"13","author":"H Kwon","year":"2013","unstructured":"Kwon H, Jung S, Cho SW, Kil DS, Roh KM, Lim JW. Solid-solution nanocrystallite formation by high-energy milling. J Nanosci Nanotechnol. 2013;13:6165\u20138.","journal-title":"J Nanosci Nanotechnol"},{"key":"250_CR29","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1023\/A:1024414423779","volume":"20","author":"K Six","year":"2003","unstructured":"Six K, Berghmans H, Leuner C, Dressman J, Van Werde K, Mullens J, et al. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, part II. Pharm Res. 2003;20:1047\u201354.","journal-title":"Pharm Res"},{"key":"250_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0378-5173(93)90111-R","volume":"89","author":"YE Hammouda","year":"1993","unstructured":"Hammouda YE, Kasim NA, Nada AH. Formulation and in vitro evaluation of verapamil HCl suppositories. Int J Pharm. 1993;89:111\u20138.","journal-title":"Int J Pharm"},{"key":"250_CR31","first-page":"257","volume":"58","author":"G Chawla","year":"2008","unstructured":"Chawla G, Bansal AK. Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives. Acta Pharm Hung. 2008;58:257\u201374.","journal-title":"Acta Pharm Hung"},{"key":"250_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2004.06.007","volume":"99","author":"M Miyake","year":"2004","unstructured":"Miyake M, Kamada N, Oka Y, Mukai T, Minami T, Toguchi H, et al. Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. J Control Release. 2004;99:63\u201371.","journal-title":"J Control Release"},{"key":"250_CR33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0939-6411(01)00187-4","volume":"52","author":"S Janicki","year":"2001","unstructured":"Janicki S, Sznitowska M, Zebrowska W, Gabiga H, Kupiec M. Evaluation of paracetamol suppositories by a pharmacopoeial dissolution test\u2014comments on methodology. Eur J Pharm Biopharm. 2001;52:249\u201354.","journal-title":"Eur J Pharm Biopharm"},{"key":"250_CR34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejpb.2006.06.004","volume":"64","author":"S Itoh","year":"2006","unstructured":"Itoh S, Teraoka N, Matsuda T, Okamoto K, Takagi T, Oo C, et al. Reciprocating dialysis tube method: periodic tapping improved in vitro release\/dissolution testing of suppositories. Eur J Pharm Biopharm. 2006;64:393\u20138.","journal-title":"Eur J Pharm Biopharm"},{"key":"250_CR35","first-page":"561","volume":"3","author":"HM Varshney","year":"2010","unstructured":"Varshney HM, Tanwar YS. Formulation, physicochemical characterisations and in vitro evaluation of flurbiprofen. J Pharm Res. 2010;3:561\u20135.","journal-title":"J Pharm Res"},{"key":"250_CR36","first-page":"344","volume":"4","author":"H Abass","year":"2012","unstructured":"Abass H, Kamel R, Abdelbary A. Metronidazole bioadhesive vaginal suppositories: formulation, in vitro and in vivo evaluation. Int J Pharm Pharm Sci. 2012;4:344\u201355.","journal-title":"Int J Pharm Pharm Sci"},{"key":"250_CR37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(92)90139-S","volume":"85","author":"C Muynck De","year":"1992","unstructured":"De Muynck C, Remon JP. Influence of fat composition on the melting behaviour and on the in vitro release of indomethacin suppositories. Int J Pharm. 1992;85:103\u201312.","journal-title":"Int J Pharm"},{"key":"250_CR38","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1248\/cpb.36.4933","volume":"36","author":"N Aoyagi","year":"1988","unstructured":"Aoyagi N, Kaniwa N, Takeda Y, Uchiyama M, Takamura F, Kido Y. Release rates of indomethacin from commercial witepsol suppositories and the bioavailabilities in rabbits and pigs. Chem Pharm Bull. 1988;36:4933\u201340.","journal-title":"Chem Pharm Bull"},{"key":"250_CR39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/03639045.2010.513984","volume":"37","author":"M Palanisamy","year":"2011","unstructured":"Palanisamy M, Khanam J. Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile. Drug Dev Ind Pharm. 2011;37:373\u201386.","journal-title":"Drug Dev Ind Pharm"},{"key":"250_CR40","first-page":"11","volume":"52","author":"CJ Blaey de","year":"1977","unstructured":"de Blaey CJ, Rutten-Kingma JJ. Biopharmaceutics of aminophylline suppositories. II. In vitro release rate during storage. Pharm Acta Helv. 1977;52:11\u20134.","journal-title":"Pharm Acta Helv"},{"key":"250_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4155\/bio.13.298","volume":"6","author":"D Zimmer","year":"2014","unstructured":"Zimmer D. New US FDA draft guidance on bioanalytical method validation versus current FDA and EMA guidelines: chromatographic methods and ISR. Bioanalysis. 2014;6:13\u20139.","journal-title":"Bioanalysis"},{"key":"250_CR42","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1248\/cpb.38.2552","volume":"38","author":"I Yamada","year":"1990","unstructured":"Yamada I, Mizuta H, Ogawa K, Tahara T. Comparative pharmacokinetics of sulpiride and N-[(1-butyl-2-pyrrolidinyl)methyl]-2-methyl-5-sulfamoyl-2,3-dihydrobenzofuran-7-carboxamide hydrochloride, a new lipophilic substituted benzamide in rats. Chem Pharm Bull. 1990;38:2552\u20135.","journal-title":"Chem Pharm Bull"},{"key":"250_CR43","first-page":"79","volume":"232","author":"AR Imondi","year":"1978","unstructured":"Imondi AR, Alam AS, Brennan JJ, Hagerman LM. Metabolism of sulpiride in man and rhesus monkeys. Arch Int Pharmacodyn Ther. 1978;232:79\u201391.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"250_CR44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/bdd.1843","volume":"34","author":"SA Helmy","year":"2013","unstructured":"Helmy SA. Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteers. Biopharm Drug Dispos. 2013;34:288\u2013301.","journal-title":"Biopharm Drug Dispos"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0250-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-014-0250-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0250-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:33:21Z","timestamp":1559619201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-014-0250-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,11]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1208\/s12249-014-0250-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,11]]}}}